LWLG

Business Context and Reporting Period

Company: Lightwave Logic, Inc. (formerly Third-Order Nanotechnologies, Inc.)
Reporting Period: Fiscal year ended December 31, 2008
Business Stage: Development stage research and development company.
Core Technology: Proprietary electro-optic polymers (plastics) engineered at the molecular level to convert electrical signals to optical signals. The company aims to replace traditional crystalline materials (e.g., lithium niobate) in telecommunications, military, and computing applications with lower-cost, higher-speed, and thermally stable alternatives.
Operations: The company has no commercial product sales to date. Operations are focused on R&D, prototype development, and securing intellectual property. It maintains a laboratory in Wilmington, Delaware, and executive offices in Newark, Delaware.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Remained at zero; the company has not yet commenced revenue-generating operations.
• Net Loss: Increased slightly by $117,158 (2.8%) compared to 2007.
• R&D Expenses: Increased significantly by $1,390,348 (95.5%) to $2.85 million. This was driven by increased employee compensation, stock-based compensation, and consulting fees related to product development.
• G&A Expenses: Decreased by $1.38 million (49.6%) to $1.40 million. Reductions were primarily due to the termination of certain management and investor relations contracts.
• Liquidity: Cash and cash equivalents declined by approximately $391,000, from $479,451 in 2007 to $88,225 in 2008.
• Financing: Raised approximately $414,000 from private stock sales and $362,770 from warrant exercises in 2008, compared to $2.3 million in stock sales in 2007.

Guidance, Outlook, Risks, and Contingencies

• Going Concern: Independent auditors have expressed substantial doubt about the company's ability to continue as a going concern due to recurring losses and negative cash flows. Management estimates current funds will sustain operations only through May 2009.
• Outlook: The company expects to continue incurring operating losses through at least 2009. Success depends on securing additional financing and achieving market acceptance for its electro-optic polymers.
• Development Status: Prototype production was temporarily halted in 2008 due to engineering setbacks. Management believes these issues have been resolved and plans to resume testing (Teng-Man protocol) to validate performance.
• Legal Contingencies:
  • SEC Investigation: The SEC is investigating a $1 million private offering conducted in 2005, alleging potential violations of registration provisions. The company is cooperating, but enforcement action remains a risk.
  • Litigation Settlement: A lawsuit filed by former Interim CEO Ronald R. Genova was settled in May 2008 for $47,500, recorded as an expense in 2008.
• Risks: High competition from established crystalline manufacturers; inability to commercialize technology; reliance on strategic partners (e.g., Photon-X, LLC); and potential loss of intellectual property if debt is secured against it.

Investor Verification Checklist

• Cash Runway: Verify the company's ability to raise capital before May 2009 to avoid operational shutdown.
• SEC Investigation Status: Confirm the current status of the SEC inquiry regarding the 2005 offering and any potential penalties or enforcement actions.
• Prototype Validation: Monitor the results of the upcoming independent Teng-Man testing to confirm the claimed 650% performance improvement over competitors.
• Stock-Based Compensation: Review the significant non-cash expenses related to stock options and warrants issued to executives and consultants, which inflate reported losses.
• Intellectual Property: Assess the strength of the 30 pending patent applications and the risk of infringement claims from competitors.